6/30 Late treatment study
Dubert et al., International Journal of Infectious Diseases,
doi:10.1016/j.ijid.2020.06.093 (Peer Reviewed)
Case report study of the first five COVID-19 patients treated with remdesivir in France
Early report on 5 ICU patients treated with remdesivir highlighting issues with usage in critically ill patients.
Dubert et al., 6/30/2020, peer-reviewed, 15 authors.
Please send us corrections, updates, or comments.
Vaccines and treatments are both extremely valuable and complementary. All
practical, effective, and safe means should be used. Elimination of COVID-19
is a race against viral evolution. No treatment, vaccine, or intervention is
100% available and effective for all current and future variants. Denying the
efficacy of any method increases the risk of COVID-19 becoming endemic; and
increases mortality, morbidity, and collateral damage. We do not provide
medical advice. Before taking any medication, consult a qualified physician
who can provide personalized advice and details of risks and benefits based
on your medical history and situation. Treatment protocols for physicians are
available from the FLCCC.
Submit